MicroMed uses Numerex technology to produce wireless heart monitor
Jun 22, 2012 (TELECOMWORLDWIRE via COMTEX) --
Miniature technology provider MicroMed Cardiovascular Inc. recently integrated the capacity for continuous wireless monitoring into its Conquest Controller. The Conquest Controller release is pending approval by regulatory agencies.
MicroMed's Conquest M2M application was built as a joint partnership with machine-to-machine technology provider Numerex Corp (NASDAQ: NMRX) using the secure, reliable Numerex FAST platform. This resulted in significant cellular cost savings and allowed remote monitoring of the device to be constant and consistent, resulting in relevant reporting around the clock.
This unprecedented innovation will allow continual remote monitoring of data from the Heart Assist 5 LVAD. As a result, clinicians, doctors and technicians will be informed automatically and in the background without requiring the patient to do anything or having to come in to the clinic or hospital facilities.
Prior to MicroMed's implementation of the M2M technology, clinicians could only access device data when the patient physically plugged the HeartAssist 5 into MicroMed's HeartAttendant so that data could be transmitted via a local Internet connection. The Internet solution provided useful data, but limited patient mobility, and meant data reporting could not be continuous.
The HeartAssist 5 was originally developed by the world famous heart surgeon Dr. Michael DeBakey in partnership with NASA. It is the smallest and lightest full support LVAD in the world, weighing only 92 grams, and is nearly silent. Because of its miniature size, it is one of the few LVADs that can be implanted above the diaphragm, adjacent to the heart, and is the most technically advanced device among a small number of competitors in this field. It is the only LVAD with a precise, direct flow measurement system and cellular-based remote monitoring. The HeartAssist 5 System consists of two devices: MicroMed HeartAssist 5 LVAD and the MicroMed Controller.
Comments on this story may be sent to firstname.lastname@example.org
[ Back To Financial Technology's Homepage ]